2025 Subject Index
PDF
Cite
Share
Request
Index
VOLUME: 5 ISSUE: 3
P: 81 - 81
December 2025

2025 Subject Index

J Mult Scler Res 2025;5(3):81-81
No information available.
No information available
Online Date: 30.12.2025
Publish Date: 30.12.2025
PDF
Cite
Share
Request
adverse events
age
3
Alemtuzumab
anti-CD52 therapy
Avascular necrosis
8
Balance
balance rehabilitation
bibliometrics
capacity
cognitive impairment
3
Expanded disability status scale (EDSS)
Familial MS
fatigue
first symptom
3
gait
Headache
hemiathrophy
Multiple sclerosis
13 ,
18 ,
26 ,
8 ,
33 ,
43 ,
neuromyelitis optica
neuromyelitis optica spectrum diseases
8
NMOSD
3
onset multiple sclerosis
optic neuritis
pathophysiology
pediatric-onset multiple sclerosis
performance
relapses
secondary autoimmunity
Sjögren’s syndrome
steroid treatment
8
systemic lupus erythematosus
visualization of similarities
walking
Web of Science